Suchergebnisse - "Demirkan, Fatih"

PubPharm (118)

1

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia : analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

enthalten in: The Lancet. Oncology | 2024

von Kater, A. | Arslan, �. | Demirkan, F. | +24

2

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA Registry

enthalten in: Haematologica | 2024

von Aiello, T. | Salmanton-Garcia, J. | Marchesi, F. | +99

3

Decoding the historical tale : COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

enthalten in: EClinicalMedicine | 2024

von Salmanton-García, J. | Marchesi, F. | Farina, F. | +99

4

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

enthalten in: Infection | 2024

von Lahmer, T. | Salmanton-García, J. | Marchesi, F. | +99

5

The mortality of COVID-19 in CML patients from 2020 until 2022 : results from the EPICOVIDEHA survey

enthalten in: Leukemia & lymphoma | 2024

von El-Ashwah, S. | Salmanton-García, J. | Bilgin, Y. | +58

6

Predicting the next pandemic : VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics

enthalten in: Travel medicine and infectious disease | 2024

von Salmanton-García, J. | Wipfler, P. | Leckler, J. | +110

7

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic : Results from the EPICOVIDEHA registry

enthalten in: Hematological oncology | 2024

von Musto, P. | Salmanton-García, J. | Sgherza, N. | +84

8

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : Results from the EPICOVIDEHA registry

enthalten in: Hematological Oncology | 2024

von Musto, P. | Salmanton‐García, J. | Sgherza, N. | +84

9

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Rossi, G. | Salmanton-García, J. | Cattaneo, C. | +99

10

Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE) : part one of a randomised, phase 2, dose optimisation study

enthalten in: The Lancet. Haematology | 2023

von Pabst, T. | Papayannidis, C. | Demirkan, F. | +23

CommentIn: Lancet Haematol. 2023 Nov;10(11):e868-e870. - PMID 37914475

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]